ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 58 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,562 | +291.1% | 7,500 | 0.0% | 0.00% | +200.0% |
| Q2 2023 | $2,445 | -24.2% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,225 | -41.3% | 7,500 | 0.0% | 0.00% | -66.7% |
| Q4 2022 | $5,490 | +9.8% | 7,500 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $5,000 | -44.4% | 7,500 | 0.0% | 0.00% | -60.0% |
| Q2 2022 | $9,000 | – | 7,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 1,510,872 | $800,762 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 122,892 | $65,133 | 0.01% |
| Bernardo Wealth Planning LLC | 38,578 | $20,446 | 0.01% |
| Key FInancial Inc | 7,500 | $5,490 | 0.00% |
| Penserra Capital Management LLC | 215,722 | $114 | 0.00% |
| King Wealth Management Group | 16,000 | $8 | 0.00% |
| Newbridge Financial Services Group, Inc. | 6,075 | $3,220 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,900 | $61,427 | 0.00% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $26,341 | 0.00% |
| Founders Capital Management | 2,000 | $1 | 0.00% |